Guided Therapeutics (GTHP) 10-Q2013 Q2 Quarterly report

Filed: 14 Aug 13, 12:00am

Content analysis

Positive
Negative
Uncertain
Constraining
Legalese
Litigous
Readability	H.S. freshman Avg

New words: accredited, added, allocated, anniversary, authoritative, beneficial, borrowed, Carlo, consent, constitute, customary, decline, delivery, difficult, dilute, dilution, directly, disposable, distributor, Edition, entitled, evenly, exit, fall, feature, fourth, framework, guidance, Health, hierarchy, identical, indirectly, initial, initially, issuable, level, long, mandatorily, mandatory, merger, Ministry, Monte, Nigerian, observable, orderly, ownership, partner, power, pro, Quoted, rata, receipt, reduction, reliance, requested, schedule, scheduled, Secretary, secured, shift, ship, shipped, shipping, Simulation, split, stockholder, subtracted, trading, Turkey, Turkish, unchanged, unobservable, unpaid

Removed: accelerated, check, electronically, Employer, exchanged, exercised, expired, filer, filing, half, Identification, Interactive, Japanese, large, launch, mark, multiyear, post, posted, preceding, registrant, Rule, shell, site, smaller, submitted, Tokyo, TRANSITION, United, Web

Search this filing

Filing tables

Export all tables to Excel

Filing exhibits

GTHP similar filings

Filing view

Default size S M L
Default font Times Arial

External links

Share this filing

EXHIBIT 32

SECTION 1350 CERTIFICATION

In connection with the Quarterly Report of Guided Therapeutics, Inc. (the "Company") on Form 10-Q for the quarter ended June 30, 2013, as filed with the Securities and Exchange Commission on the date hereof (the "Report"), I, Mark L. Faupel, President, Chief Executive Officer and acting Chief Financial Officer of the Company, certify, pursuant to 18 U.S.C. Sec. 1350, as adopted pursuant to Sec 906 of the Sarbanes-Oxley Act of 2002, that to the best of my knowledge and belief:

(1) the Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

(2) the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

Date: August 14, 2013

/s/ MARK L. FAUPEL

Name: Mark L. Faupel

Title: President, Chief Executive Officer and acting Chief Financial Officer

We use cookies on this site to provide a more responsive and personalized service. Continuing to browse, clicking I Agree, or closing this banner indicates agreement. See our Cookie Policy for more information.